0.22HKD
179.87 MHKD
2.27 BHKD
294.54 M
About ZHONGZHI PHARMACEUTICAL HLDGS LTD
Sector
CEO
Ying Feng Lai
Headquarters
Zhongshan
Website
Employees (FY)
2.64 K
Founded
2014
ISIN
KYG989611085
FIGI
BBG009J4NMV3
Zhongzhi Pharmaceutical Holdings Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments. The Pharmaceutical Manufacturing segment deals with the research, development, manufacturing, and sale of Chinese patent medicines and decoction pieces. The Operation of Chain Pharmacies segment manages self-operated chain and medical insurance designated pharmacies. The company was founded by Zhi Tian Lai on September 12, 2014 and is headquartered in Zhongshan, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 3737 is 1.23 HKD — it has decreased by 0.81% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange ZHONGZHI PHARMACEUTICAL HLDGS LTD stocks are traded under the ticker 3737.
ZHONGZHI PHARMACEUTICAL HLDGS LTD is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
3737 stock is 1.63% volatile and has beta coefficient of 0.25. Check out the list of the most volatile stocks — is ZHONGZHI PHARMACEUTICAL HLDGS LTD there?
Yes, you can track ZHONGZHI PHARMACEUTICAL HLDGS LTD financials in yearly and quarterly reports right on TradingView.
3737 stock has risen by 3.36% compared to the previous week, the month change is a 12.77% fall, over the last year ZHONGZHI PHARMACEUTICAL HLDGS LTD has showed a 8.85% increase.
3737 net income for the last quarter is 30.11 M HKD, while the quarter before that showed 152.57 M HKD of net income which accounts for −80.26% change. Track more ZHONGZHI PHARMACEUTICAL HLDGS LTD financial stats to get the full picture.
Today ZHONGZHI PHARMACEUTICAL HLDGS LTD has the market capitalization of 1.05 B, it has increased by 1.69% over the last week.
ZHONGZHI PHARMACEUTICAL HLDGS LTD dividend yield was 6.34% in 2023, and payout ratio reached 42.37%. The year before the numbers were 8.26% and 61.60% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 3737 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZHONGZHI PHARMACEUTICAL HLDGS LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 2.64 K employees. See our rating of the largest employees — is ZHONGZHI PHARMACEUTICAL HLDGS LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZHONGZHI PHARMACEUTICAL HLDGS LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZHONGZHI PHARMACEUTICAL HLDGS LTD stock shows the neutral signal. See more of ZHONGZHI PHARMACEUTICAL HLDGS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ZHONGZHI PHARMACEUTICAL HLDGS LTD EBITDA is 363.01 M HKD, and current EBITDA margin is 15.88%. See more stats in ZHONGZHI PHARMACEUTICAL HLDGS LTD financial statements.